Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine Full Text
The Journal of Infectious Diseases, 04/10/2012
Micek MA et al. – Nevirapine (NVP)–mutants decayed to <2% in 24/35 (68.6%) at a median 6 months postpartum, with no differences based on ZDV use. Short–course ZDV was associated with reduced NVP–resistance mutations among women taking sdNVP.